Researchers with the Advanced Science Research Center at the CUNY Graduate Center (CUNY ASRC) have unveiled a critical ...

Scientists uncover how disrupted lipid metabolism fuels chronic inflammation in colorectal cancer, offering insights into new ...

Recent advancements in understanding the molecular basis of the prostaglandin D2 receptor (DP2) have significant implications ...

总部位于芝加哥的制药公司 ResQ Pharma, Inc. 正在开发和商业化创新药物疗法，该公司今天宣布其 Lipid Rescue Kit 已获得 PDUFA（处方药用户付费法案）的批准，批准日期为2025 年 6 月 2 日。如果获得批准，该套件将通过快速准确地输注临床推荐剂量的脂质乳剂来治疗 LAST，该剂量已被证明可以安全有效地抵消毒性并挽救患者生命。LAST 是一种罕见但可能致命的事件 ...

2024年12月13日，中国科学院上海药物研究所徐华强团队在 PNAS 上发表了题为“Molecular basis of lipid and ligand regulation of prostaglandin receptor DP2”的在线文章 ...

Penn Engineers have modified lipid nanoparticles (LNPs) -; the revolutionary technology behind the COVID-19 mRNA vaccines -; to not only cross the blood-brain barrier (BBB) but also to target specific ...

Engineers have developed a lipid nanoparticle (LNP) that delivers mRNA therapeutic to the placenta to treat pre-eclampsia in mice with human trials on the horizon.

Penn Engineers have developed a Lipid Nanoparticle (LNP) that delivers mRNA theraputic to the placenta to treat pre-eclampsia ...

This paper presents the important discovery that lipid metabolic imbalance caused by Snail, an EMT-related transcription factor, contributes to the acquisition of chemoresistance in cancer cells.